Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
CAPS Rating:
Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.
RSS Headlines
Fool UK
Recs
Very bullish chart pattern and bullish articles are chances for their endometriosis drug.